Pharmaceutical industry : innovation and developments / David A. Mancuso and Isobel M. Grenada, editors.
2011
Formats
| Format | |
|---|---|
| BibTeX | |
| MARCXML | |
| TextMARC | |
| MARC | |
| DublinCore | |
| EndNote | |
| NLM | |
| RefWorks | |
| RIS |
Items
Details
Uniform Title
Ebrary electronic monographs.
Title
Pharmaceutical industry : innovation and developments / David A. Mancuso and Isobel M. Grenada, editors.
Added Author
Added Corporate Author
Imprint
Hauppauge, N.Y. : Nova Science, [2011]
Copyright
©2011
Description
ix, 182 pages : illustrations.
Series
Business issues, competition and entrepreneurship series.
Pharmacology-research, safety testing, and regulation series.
Pharmacology-research, safety testing, and regulation series.
Formatted Contents Note
Authorized generic pharmaceuticals : effects on innovation / John R. Thomas
Authorized generics : an interim report / FTC
Remarks of J. Thomas Rosch, Commissioner, Federal Trade Commission, before the World Generic Medicine Congress, hearing on "pay-for-delay settlements, authorized generics, and follow-on biologies : thoughts on the how competition law can best protect consumer welfare in the pharmaceutical context"
Federal R&D, drug discovery, and pricing : insights from the NIH-university-industry relationship / Wendy H. Schacht
Pharmaceutical R&D and the evolving market for prescription drugs / CBO
Federal taxation of the drug industry and its effects on new drug development / Gary Guenther
Pharmaceutical patent litigation settlements : implications for competition and innovation / John R. Thomas
FDA's authority to regulate drug compounding : a legal analysis / Jennifer Staman
Promotional spending for prescription drugs / CBO.
Authorized generics : an interim report / FTC
Remarks of J. Thomas Rosch, Commissioner, Federal Trade Commission, before the World Generic Medicine Congress, hearing on "pay-for-delay settlements, authorized generics, and follow-on biologies : thoughts on the how competition law can best protect consumer welfare in the pharmaceutical context"
Federal R&D, drug discovery, and pricing : insights from the NIH-university-industry relationship / Wendy H. Schacht
Pharmaceutical R&D and the evolving market for prescription drugs / CBO
Federal taxation of the drug industry and its effects on new drug development / Gary Guenther
Pharmaceutical patent litigation settlements : implications for competition and innovation / John R. Thomas
FDA's authority to regulate drug compounding : a legal analysis / Jennifer Staman
Promotional spending for prescription drugs / CBO.
Bibliography, etc. Note
Includes bibliographical references and index.
Linked Resources
Language
English
Reproduction
Electronic reproduction. Palo Alto, Calif. : ebrary, 2013. Available via World Wide Web. Access may be limited to ebrary affiliated libraries.
ISBN
9781612093949 hardcover
9781621004394 e-book
9781621004394 e-book
Record Appears in